🔔 Leadership Alert
Fortis Healthcare appoints Dr. Ashutosh Raghuvanshi as CEO, replacing Bhavdeep Singh who resigned in November.
Fortis Healthcare Ltd Analyst Rating
based on 14 analysts
85.71%
Buy
7.14%
Hold
7.14%
Sell
Based on 14 analysts offering long term price targets for Fortis Healthcare Ltd. An average target of ₹685.36
Source: S&P Global Market Intelligence
Fortis Healthcare Ltd Share analysis
Fortis Healthcare Ltd price forecast by 14 analysts
Upside of4.19%
High
₹728
Target
₹685.36
Low
₹550
Fortis Healthcare Ltd target price ₹685.36, a slight upside of 4.19% compared to current price of ₹680.7. According to 14 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Fortis Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2026:25.06%
Forecast
Actual
Including amortisation and stock based compensations
Fortis Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2026:66.58%
Forecast
Actual
Source: S&P Global Market Intelligence
Fortis Healthcare Ltd Performance
Day's Low
Day's High
₹654.9₹69152 Week's Low
52 Week's High
₹356.2₹691
| Returns % | |
| 1 Month Return | + 8.13 % |
| 3 Month Return | + 24.96 % |
| 1 Year Return | + 76.64 % |
| Market Stats | |
| Previous Close | ₹657.80 |
| Open | ₹655.00 |
| Volume | 54.77L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹49,661.15Cr |
Fortis Healthcare Ltd Key Statistics
| P/E Ratio | 75.7 |
| PEG Ratio | 52.93 |
| Market Cap | ₹49,661.15 Cr |
| P/B Ratio | 3.49 |
| EPS | 8.55 |
| Dividend Yield | 0.24 |
| Sector | Healthcare |
| ROE | 1.37 |
Fortis Healthcare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹49,661.15 Cr | 73.9% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹96,999.34 Cr | 158.58% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹96,147.36 Cr | 71.89% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
| BUY | ₹25,790.33 Cr | 64.12% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹22,695.88 Cr | 36.89% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Fortis Healthcare Ltd Mutual Fund Holdings
About Fortis Healthcare Ltd
Fortis Healthcare Ltd. is well known for its top products, such as medical equipment, pharmaceuticals, diagnostics, and medical devices. It also has a wide range of popular brands, such as Fortis Health, Fortis Care, and Fortis Plus.
Share Price: ₹680.70 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹49,661.15Cr as of today
Revenue: ₹1,988.39Cr as on September 2024 (Q3 24)
Net Profit: ₹193.08Cr as on September 2024 (Q3 24)
Listing date: 09 May, 2007
Chairperson Name: Ravi Rajagopal
| Organisation | Fortis Healthcare Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
What's happening today
Today's Timeline - Invalid Date
10:20 AM
-Fortis Healthcare shares surged nearly 3% to ₹674.80, marking an all-time high amid positive market sentiment.
11:00 AM
-Fortis Healthcare shares reached fresh 52-week highs today.
12:58 PM
-Fortis Healthcare stock gained over 4% to hit ₹691, with an 83% increase over the past year.
Key events for Fortis Healthcare Ltd
Fortis Healthcare Hits New Highs Amid Positive Developments - 21 Nov, 2024
Fortis Healthcare shares surged to a 52-week high of ₹691, reflecting an 83% annual gain. The stock's rise follows the appointment of Dr. Ashutosh Raghuvanshi as CEO and strong market performance.
Fortis Healthcare Maintains Buy Rating with Revised Target - 12 Nov, 2024
Fortis Healthcare's Q2FY25 EBITDA exceeded estimates, driven by improved margins and profitability in diagnostics. The company plans to invest Rs 18bn in diagnostics, raising its stake to 88%. Analysts maintain a Buy rating with a revised target price of Rs 710/share, anticipating strong EBITDA growth.
Fortis Healthcare Reports Modest Profit Growth - 10 Nov, 2024
Fortis Healthcare posted a 1.6% increase in net profit to ₹176.5 crore, with revenue rising 12.3% to ₹1,988.4 crore. EBITDA grew significantly by 31.7%, improving margins to 21.9%.
Fortis Healthcare Reports Strong Q2 Earnings Growth - 08 Nov, 2024
Fortis Healthcare's Q2 FY25 results show a 5% increase in net profit to Rs 193 crore and a 12% rise in revenue to Rs 1,988 crore, driven by strong hospital performance. The company is progressing on plans to add 700 beds this fiscal year.
Fortis Healthcare Stock Accumulation Recommended - 01 Nov, 2024
Religare Broking advises buying Fortis Healthcare shares in the range of ₹623-628, with target prices of ₹665-680 and a stop loss at ₹602.
Fortis Healthcare Gains CCI Approval for Stake Acquisition - 30 Oct, 2024
Fortis Healthcare has received approval from the Competition Commission of India to acquire an additional 31.52% stake in Agilus Diagnostics, increasing its ownership to 89.2%. This acquisition strengthens Fortis's position in the healthcare sector.
Fortis Healthcare Secures CCI Approval for Agilus Stake - 29 Oct, 2024
Fortis Healthcare has received approval from the CCI to acquire an additional 31.52% stake in Agilus Diagnostics for Rs 1,780 crore, raising its total ownership to 89.2%. This move strengthens Fortis's position in the diagnostics sector.
Insights on Fortis Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, FORTIS has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 23.31% to 25.26% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 165.96 Cr → 176.46 Cr (in ₹), with an average increase of 6.0% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 1.69K Cr → 2.00K Cr (in ₹), with an average increase of 5.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, FORTIS stock has moved up by 2.9%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 31.17% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 191.3% return, outperforming this stock by 44.8%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 13.21% to 12.84% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 27.52% to 27.23% in Sep 2024 quarter
Fortis Healthcare Ltd Financials
Index Inclusions
Fortis Healthcare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 31.17% | 0.00 | |
| Foreign Institutions | 25.26% | 8.38 | |
| Mutual Funds | 27.23% | ||
| Retail Investors | 12.84% | ||
| Others | 3.51% |
Fortis Healthcare Ltd Key Indicators
Fortis Healthcare Ltd Valuation
Fortis Healthcare Ltd in the last 5 years
Lowest (-166.21x)
June 25, 2021
Today (75.70x)
November 19, 2024
Industry (96.41x)
November 19, 2024
Highest (165.13x)
April 9, 2020
Fortis Healthcare Ltd Earnings and Dividends
Fortis Healthcare Ltd Earnings Results
Fortis Healthcare Ltd’s net profit jumped 1.58% since last year same period to ₹176.46Cr in the Q2 2024-2025. On a quarterly growth basis, Fortis Healthcare Ltd has generated 6.33% jump in its net profits since last 3-months.
Read More about Earnings ResultsFortis Healthcare Ltd Dividends May,2024
In the quarter ending March 2024, Fortis Healthcare Ltd has declared dividend of ₹1 - translating a dividend yield of 0.30%.
Read More about Dividends
Fortis Healthcare Ltd Technicals Summary
Bearish
Neutral
Bullish
Fortis Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Fortis Healthcare Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Fortis Healthcare Ltd shares.
Fortis Healthcare Ltd (FORTIS) share price today is ₹680.7
Fortis Healthcare Ltd is listed on NSE
Fortis Healthcare Ltd is listed on BSE
- Today’s highest price of Fortis Healthcare Ltd is ₹691.
- Today’s lowest price of Fortis Healthcare Ltd is ₹654.9.
PE Ratio of Fortis Healthcare Ltd is 75.7
PE ratio = Fortis Healthcare Ltd Market price per share / Fortis Healthcare Ltd Earnings per share
Today’s traded volume of Fortis Healthcare Ltd(FORTIS) is 54.77L.
Today’s market capitalisation of Fortis Healthcare Ltd(FORTIS) is ₹49661.15Cr.
| Fortis Healthcare Ltd(FORTIS | Price |
|---|---|
52 Week High | ₹691 |
52 Week Low | ₹356.2 |
Fortis Healthcare Ltd(FORTIS) share price is ₹680.7. It is down -1.49% from its 52 Week High price of ₹691
Fortis Healthcare Ltd(FORTIS) share price is ₹680.7. It is up 91.10% from its 52 Week Low price of ₹356.2
| Fortis Healthcare Ltd(FORTIS | Returns |
|---|---|
1 Day Returns | 22.9% |
1 Month Returns | 8.13% |
3 Month Returns | 24.96% |
1 Year Returns | 76.64% |